289 related articles for article (PubMed ID: 27073199)
21. Impact of cisplatin-induced acute kidney injury on long-term renal function in patients with solid tumors.
Hino A; Muto S; Shimada Y; Hori S; Isotani S; Nagata M; Horie S
Clin Exp Nephrol; 2023 Jun; 27(6):506-518. PubMed ID: 36941500
[TBL] [Abstract][Full Text] [Related]
22. Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes.
Helgason D; Long TE; Helgadottir S; Palsson R; Sigurdsson GH; Gudbjartsson T; Indridason OS; Gudmundsdottir IJ; Sigurdsson MI
J Nephrol; 2018 Oct; 31(5):721-730. PubMed ID: 30187381
[TBL] [Abstract][Full Text] [Related]
23. Long-term nephrotoxicity in adult survivors of childhood cancer.
Dekkers IA; Blijdorp K; Cransberg K; Pluijm SM; Pieters R; Neggers SJ; van den Heuvel-Eibrink MM
Clin J Am Soc Nephrol; 2013 Jun; 8(6):922-9. PubMed ID: 23411430
[TBL] [Abstract][Full Text] [Related]
24. Effects of deferasirox dose and decreasing serum ferritin concentrations on kidney function in paediatric patients: an analysis of clinical laboratory data from pooled clinical studies.
Bird ST; Swain RS; Tian F; Okusanya OO; Waldron P; Khurana M; Durmowicz EL; Ma Y; Major JM; Gelperin K
Lancet Child Adolesc Health; 2019 Jan; 3(1):15-22. PubMed ID: 30455109
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
[TBL] [Abstract][Full Text] [Related]
26. Incidence and predictors of early and delayed renal function decline after aortic aneurysm repair in the Vascular Quality Initiative database.
Novak Z; Zaky A; Spangler EL; McFarland GE; Tolwani A; Beck AW
J Vasc Surg; 2021 Nov; 74(5):1537-1547. PubMed ID: 34019992
[TBL] [Abstract][Full Text] [Related]
27. Contrast volume to estimated glomerular filtration rate ratio for prediction of contrast-induced acute kidney injury after cardiac catheterization in adults with congenital heart disease.
Gellis L; Gauvreau K; Ferguson M; Bergersen L; Shafer K; Porras D
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1301-1308. PubMed ID: 30196559
[TBL] [Abstract][Full Text] [Related]
28. A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity.
Dhillon P; Amir E; Lo M; Kitchlu A; Chan C; Cochlin S; Yip P; Chen E; Lee R; Ng P
J Oncol Pharm Pract; 2019 Jun; 25(4):875-883. PubMed ID: 29722605
[TBL] [Abstract][Full Text] [Related]
29. No increased acute kidney injury rate through giving an intravenous colistin loading dose in pediatric patients.
Wacharachaisurapol N; Kawichai S; Chanakul A; Puthanakit T
Int J Infect Dis; 2021 May; 106():91-97. PubMed ID: 33771669
[TBL] [Abstract][Full Text] [Related]
30. Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial.
Baek SH; Kim SH; Kim JW; Kim YJ; Lee KW; Na KY
Trials; 2015 May; 16():239. PubMed ID: 26021829
[TBL] [Abstract][Full Text] [Related]
31. Kidney function decline after a non-dialysis-requiring acute kidney injury is associated with higher long-term mortality in critically ill survivors.
Lai CF; Wu VC; Huang TM; Yeh YC; Wang KC; Han YY; Lin YF; Jhuang YJ; Chao CT; Shiao CC; Tsai PR; Hu FC; Chou NK; Ko WJ; Wu KD;
Crit Care; 2012 Jul; 16(4):R123. PubMed ID: 22789111
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function.
Ha SH; Park JH; Jang HR; Huh W; Lim HY; Kim YG; Kim DJ; Oh HY; Lee JE
BMC Cancer; 2014 Dec; 14():906. PubMed ID: 25466872
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
34. Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury.
Zhang LW; Luo MQ; Xie XW; You ZB; Zeng JL; Lin MQ; Chen LC; Lin KY; Guo YS
J Am Heart Assoc; 2023 Jan; 12(1):e027980. PubMed ID: 36565177
[TBL] [Abstract][Full Text] [Related]
35. Dialysis requirement, long-term major adverse cardiovascular events (MACE) and all-cause mortality in hospital acquired acute kidney injury (AKI): a propensity-matched cohort study.
Omotoso BA; Abdel-Rahman EM; Xin W; Ma JZ; Scully KW; Arogundade FA; Balogun RA
J Nephrol; 2016 Dec; 29(6):847-855. PubMed ID: 27307250
[TBL] [Abstract][Full Text] [Related]
36. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
[TBL] [Abstract][Full Text] [Related]
37. Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney Function.
Siew ED; Abdel-Kader K; Perkins AM; Greevy RA; Parr SK; Horner J; Vincz AJ; Denton J; Wilson OD; Hung AM; Robinson-Cohen C; Matheny ME
Am J Kidney Dis; 2020 Feb; 75(2):204-213. PubMed ID: 31537394
[TBL] [Abstract][Full Text] [Related]
38. Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.
McMahon KR; Rod Rassekh S; Schultz KR; Pinsk M; Blydt-Hansen T; Mammen C; Tsuyuki RT; Devarajan P; Cuvelier GD; Mitchell LG; Baruchel S; Palijan A; Carleton BC; Ross CJ; Zappitelli M;
Can J Kidney Health Dis; 2017; 4():2054358117690338. PubMed ID: 28270931
[TBL] [Abstract][Full Text] [Related]
39. Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity.
Mizuno T; Hayashi T; Shimabukuro Y; Murase M; Hayashi H; Ishikawa K; Takahashi K; Yuzawa Y; Yamada S; Nagamatsu T
Oncology; 2016; 90(6):313-20. PubMed ID: 27225867
[TBL] [Abstract][Full Text] [Related]
40. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
